In the past week, THC stock has gone down by -4.45%, with a monthly gain of 3.68% and a quarterly surge of 1.76%. The volatility ratio for the week is 8.57%, and the volatility levels for the last 30 days are 5.03% for Tenet Healthcare Corp The simple moving average for the last 20 days is 2.31% for THC stock, with a simple moving average of -8.56% for the last 200 days.
Is It Worth Investing in Tenet Healthcare Corp (NYSE: THC) Right Now?
Tenet Healthcare Corp (NYSE: THC) has a price-to-earnings ratio that is above its average at 4.07x. The stock has a 36-month beta value of 1.59. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 6 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for THC is 93.02M, and at present, short sellers hold a 4.16% of that float. On April 10, 2025, the average trading volume of THC was 1.55M shares.
THC) stock’s latest price update
Tenet Healthcare Corp (NYSE: THC)’s stock price has plunge by 9.67relation to previous closing price of 119.51. Nevertheless, the company has seen a -4.45% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-04-09 that DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services comp.
Analysts’ Opinion of THC
Many brokerage firms have already submitted their reports for THC stocks, with Morgan Stanley repeating the rating for THC by listing it as a “Overweight.” The predicted price for THC in the upcoming period, according to Morgan Stanley is $165 based on the research report published on March 26, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see THC reach a price target of $175. The rating they have provided for THC stocks is “Buy” according to the report published on February 26th, 2025.
JP Morgan gave a rating of “Overweight” to THC, setting the target price at $175 in the report published on December 17th of the previous year.
THC Trading at -0.15% from the 50-Day Moving Average
After a stumble in the market that brought THC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.44% of loss for the given period.
Volatility was left at 5.03%, however, over the last 30 days, the volatility rate increased by 8.57%, as shares surge +8.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.16% lower at present.
During the last 5 trading sessions, THC fell by -4.45%, which changed the moving average for the period of 200-days by -2.37% in comparison to the 20-day moving average, which settled at $128.11. In addition, Tenet Healthcare Corp saw 3.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at THC starting from KERREY J ROBERT, who sale 9,525 shares at the price of $125.43 back on Mar 11 ’25. After this action, KERREY J ROBERT now owns 27,378 shares of Tenet Healthcare Corp, valued at $1,194,752 using the latest closing price.
KERREY J ROBERT, the Director of Tenet Healthcare Corp, proposed sale 9,525 shares at $125.80 during a trade that took place back on Mar 11 ’25, which means that KERREY J ROBERT is holding shares at $1,198,245 based on the most recent closing price.
Stock Fundamentals for THC
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.36 for the gross margin
The net margin for Tenet Healthcare Corp stands at 0.15. The total capital return value is set at 0.14. Equity return is now at value 110.75, with 11.18 for asset returns.
Based on Tenet Healthcare Corp (THC), the company’s capital structure generated 0.76 points at debt to capital in total, while cash flow to debt ratio is standing at 0.16. The debt to equity ratio resting at 3.16. The interest coverage ratio of the stock is 4.04.
Currently, EBITDA for the company is 6.89 billion with net debt to EBITDA at 2.36. When we switch over and look at the enterprise to sales, we see a ratio of 1.09. The receivables turnover for the company is 5.72for trailing twelve months and the total asset turnover is 0.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.
Conclusion
To sum up, Tenet Healthcare Corp (THC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
